Skip to main content

Favorite Annette F's Form 4 filing

West Pharmaceutical Services Inc (WST) · filed May 2, 2023

Accession no.
0001562180-23-003794
Filed
May 2, 2023
Trade date
May 1, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.76M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Favorite Annette FCIK 0001654975Officer (Sr. VP & Chief HR Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 1, 2023Common StockMOption exerciseAcquired+13,012$59.64+$776,035.6827,888.96Direct
May 1, 2023Common StockSSaleDisposed−9,425$365.47−$3,444,554.7518,463.96Direct
May 1, 2023Common StockSSaleDisposed−2,687$366.46−$984,678.0215,776.96Direct
May 1, 2023Common StockSSaleDisposed−900$367.45−$330,70514,876.96Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 1, 2023Common StockMOption exerciseDisposed−13,012$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)